0001485003-22-000020.txt : 20220223 0001485003-22-000020.hdr.sgml : 20220223 20220223203622 ACCESSION NUMBER: 0001485003-22-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cannell Thomas R CENTRAL INDEX KEY: 0001637822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 22666004 MAIL ADDRESS: STREET 1: C/O SESEN BIO, INC. STREET 2: 245 FIRST STREET, SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 4 1 wf-form4_164566653278711.xml FORM 4 X0306 4 2022-02-18 0 0001485003 Sesen Bio, Inc. SESN 0001637822 Cannell Thomas R C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 1 1 0 0 President and CEO Common Stock 2022-02-18 4 A 0 606800 0 A 606800 D Represents restricted stock units ("RSUs") which shall vest annually in equal amounts over a four-year period following the grant date, so long as the reporting person remains employed by Sesen Bio, Inc.(the "Company"). Each RSU represents a contingent right to receive one share of the Company's common stock. Based on market analysis by Radford of public, pre-commercial and commercial biopharmaceutical companies, the compensation committee of the Company recommended to the Company's board of directors, and the board of directors approved, the grant to the reporting person. /s/ Thomas R. Cannell 2022-02-23